US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Unicycive Therapeutics, Inc.

0.6511

-0.0005-0.08%

Volume:331.33K

Turnover:218.12K

Market Cap:77.94M

PE:-1.15

High:0.6700

Open:0.6600

Low:0.6500

Close:0.6516

Loading ...

Overview Company News Filings

Unicycive Therapeutics Inc. Presents New Developments in Kidney Disease Treatments, Highlighting OLC and UN-494 Progress

Unicycive Therapeutics Inc : Guggenheim Initiates Coverage With Buy Rating; Price Target $6

THOMSON REUTERS

Buy Rating for Unicycive Therapeutics: Competitive Advantages of Oxylanthanum Carbonate in Hyperphosphatemia Treatment

Unicycive Therapeutics: Buy Rating on Imminent FDA Approval and Market Potential of Oxylanthanum Carbonate

Unicycive presents new patient-level data from Phase 2 study of OLC

Unicycive Presents New Patient-Level Data Underscoring Challenges Faced with Current Phosphate Binders and Highlighting the Potential of Oxylanthanum Carbonate to Address Barriers to Adherence for Patients with Hyperphosphatemia on Dialysis

Unicycive Therapeutics, Inc. : H.c. Wainwright Raises Target Price to $7.5 From $4

THOMSON REUTERS

Unicycive Therapeutics reports FY24 EPS (56c), consensus (51c)

Unicycive Therapeutics Inc: Believes That It Has Sufficient Resources to Fund Planned Operations Into 2026

THOMSON REUTERS

Unicycive Therapeutics FY 2024 GAAP EPS $(0.56) Misses $(0.50) Estimate, As Of December 31, 2024, Cash And Cash Equivalents Of $26.1M, Sufficient To Fund Planned Operations Into 2026

Unicycive Therapeutics Announces Full Year 2024 Financial Results and Provides Business Update

Calendar of U.S. Earnings Expected in the Week Ahead

DaVita Stock Declines 1.2% in 3 Months: Here's How to Play

Calendar of U.S. Earnings Expected in the Week Ahead

Unicycive to Highlight Patient Reported Outcomes Data at Upcoming Medical Meetings Showing Oxylanthanum Carbonate Reduced Pill Burden and Improved Adherence in Treatment of Hyperphosphatemia

THOMSON REUTERS

Noble Financial Sticks to Its Buy Rating for Unicycive Therapeutics (UNCY)

Unicycive Therapeutics Announces the Publication of Preclinical Data on Synergies Between Oxylanthanum Carbonate and Tenapanor in American Society of Nephrology Journal Kidney360

Unicycive Therapeutics Price Target Maintained With a $4.00/Share by HC Wainwright & Co.

Buy Rating for Unicycive Therapeutics Driven by Promising OLC Treatment and Reduced Pill Burden

Unicycive announces publication of patient perspectives on phosphate management

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/UNCY/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"UNCY","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"UNCY\",,,,,undefined,":{"symbol":"UNCY","market":"US","secType":"STK","nameCN":"Unicycive Therapeutics, Inc.","latestPrice":0.6511,"timestamp":1746128081555,"preClose":0.6516,"halted":0,"volume":331334,"delay":0,"floatShares":70600827,"shares":119705026,"eps":-0.564662,"marketStatus":"Trading","change":-0.0005,"latestTime":"05-01 15:35:40 EDT","open":0.66,"high":0.67,"low":0.65,"amount":218124.2296142,"amplitude":0.030694,"askPrice":0.6612,"askSize":600,"bidPrice":0.6512,"bidSize":900,"shortable":3,"etf":0,"ttmEps":-0.564662,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1746129600000},"marketStatusCode":2,"adr":0,"listingDate":1623988800000,"exchange":"NASDAQ","adjPreClose":0.6516,"preHourTrading":{"tag":"盘前","latestPrice":0.666,"preClose":0.6516,"latestTime":"09:29 EDT","volume":7420,"amount":4936.636558,"timestamp":1746106177050},"postHourTrading":{"tag":"盘后","latestPrice":0.6461,"preClose":0.6516,"latestTime":"19:27 EDT","volume":42530,"amount":27883.3171,"timestamp":1746055652717},"volumeRatio":0.839098},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"UNCY\",,,,,undefined,":{"symbol":"UNCY","floatShares":70600827,"roa":"-87.54%","roe":"-2028.11%","lyrEps":-0.564662,"volumeRatio":0.839098,"shares":119705026,"dividePrice":0,"high":0.67,"amplitude":0.030694,"preClose":0.6516,"low":0.65,"week52Low":0.202,"pbRate":"10.49","week52High":1.21,"institutionHeld":0,"latestPrice":0.6511,"committee":0.2,"eps":-0.564662,"divideRate":0,"volume":331334,"delay":0,"ttmEps":-0.564662,"open":0.66,"prevYearClose":0.7942,"prevWeekClose":0.64,"prevMonthClose":0.6516,"prevQuarterClose":0.5749,"fiveDayClose":0.64,"twentyDayClose":0.5485,"sixtyDayClose":0.6013},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"UNCY\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2532863248","title":"Unicycive Therapeutics Inc. Presents New Developments in Kidney Disease Treatments, Highlighting OLC and UN-494 Progress","url":"https://stock-news.laohu8.com/highlight/detail?id=2532863248","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532863248?lang=en_us&edition=fundamental","pubTime":"2025-05-02 01:48","pubTimestamp":1746121714,"startTime":"0","endTime":"0","summary":"Unicycive Therapeutics Inc., listed on NASDAQ under the ticker UNCY, presented its May 2025 corporate presentation highlighting its focus on kidney disease treatments. The company's diversified portfolio includes its lead asset, Oxylanthanum Carbonate , aimed at treating hyperphosphatemia in chronic kidney disease patients on dialysis. The New Drug Application  for OLC is currently under review, with a PDUFA date set for June 28, 2025. Unicycive is also developing UN-494 for acute kidney injury and chronic kidney disease. The presentation outlines strategies for OLC's market launch, emphasizing awareness, market shaping, reimbursement facilitation, and commercial operations. It notes a significant market opportunity in hyperphosphatemia, valued at over $1 billion in the US. You can access the full presentation through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250501:nNDL1jXNQs:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["UNCY","BK4539","BK4139"],"gpt_icon":0},{"id":"2529047874","title":"Unicycive Therapeutics Inc : Guggenheim Initiates Coverage With Buy Rating; Price Target $6","url":"https://stock-news.laohu8.com/highlight/detail?id=2529047874","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529047874?lang=en_us&edition=fundamental","pubTime":"2025-04-21 19:08","pubTimestamp":1745233691,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250421:nFWN3QZ0U5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","BK4139","UNCY"],"gpt_icon":0},{"id":"2526517706","title":"Buy Rating for Unicycive Therapeutics: Competitive Advantages of Oxylanthanum Carbonate in Hyperphosphatemia Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2526517706","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526517706?lang=en_us&edition=fundamental","pubTime":"2025-04-11 18:36","pubTimestamp":1744367814,"startTime":"0","endTime":"0","summary":"Ed Arce, an analyst from H.C. Wainwright, maintained the Buy rating on Unicycive Therapeutics (UNCY – Research Report). The associated price target...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/buy-rating-for-unicycive-therapeutics-competitive-advantages-of-oxylanthanum-carbonate-in-hyperphosphatemia-treatment?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/buy-rating-for-unicycive-therapeutics-competitive-advantages-of-oxylanthanum-carbonate-in-hyperphosphatemia-treatment?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LENZ","UNCY"],"gpt_icon":0},{"id":"2526636771","title":"Unicycive Therapeutics: Buy Rating on Imminent FDA Approval and Market Potential of Oxylanthanum Carbonate","url":"https://stock-news.laohu8.com/highlight/detail?id=2526636771","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526636771?lang=en_us&edition=fundamental","pubTime":"2025-04-11 16:35","pubTimestamp":1744360526,"startTime":"0","endTime":"0","summary":"Benchmark Co. analyst Bruce Jackson maintained a Buy rating on Unicycive Therapeutics (UNCY – Research Report) yesterday and set a price target of ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/unicycive-therapeutics-buy-rating-on-imminent-fda-approval-and-market-potential-of-oxylanthanum-carbonate?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/unicycive-therapeutics-buy-rating-on-imminent-fda-approval-and-market-potential-of-oxylanthanum-carbonate?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["UNCY","LENZ"],"gpt_icon":0},{"id":"2526565197","title":"Unicycive presents new patient-level data from Phase 2 study of OLC","url":"https://stock-news.laohu8.com/highlight/detail?id=2526565197","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526565197?lang=en_us&edition=fundamental","pubTime":"2025-04-10 20:17","pubTimestamp":1744287423,"startTime":"0","endTime":"0","summary":"Unicycive Therapeutics (UNCY) announced new patient-reported outcomes data from its pivotal Phase 2 study of OLC as well as from a new survey condu...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/unicycive-presents-new-patient-level-data-from-phase-2-study-of-olc?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/unicycive-presents-new-patient-level-data-from-phase-2-study-of-olc?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","UNCY","BK4539"],"gpt_icon":0},{"id":"2526563956","title":"Unicycive Presents New Patient-Level Data Underscoring Challenges Faced with Current Phosphate Binders and Highlighting the Potential of Oxylanthanum Carbonate to Address Barriers to Adherence for Patients with Hyperphosphatemia on Dialysis","url":"https://stock-news.laohu8.com/highlight/detail?id=2526563956","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526563956?lang=en_us&edition=fundamental","pubTime":"2025-04-10 20:00","pubTimestamp":1744286400,"startTime":"0","endTime":"0","summary":"– Patient-reported outcomes from Phase 2 trial of oxylanthanum carbonate  demonstrate high patient satisfaction with OLC compared to their prior phosphate lowering therapy –。– Findings from a patient survey conducted in partnership with the National Kidney Foundation  showed excessive number and large size of phosphate binder pills to be top barriers to consistent medication use –。Patient-Reported Outcomes DataPatient-reported outcomes from the open-label Phase 2 UNI-OLC-201 clinical trial compared patients’ satisfaction with their pre-trial phosphate binders versus OLC at the end of the study based on responses to a questionnaire completed by 80 patients. This research will be presented by Guru Reddy, PhD., in the poster titled \"Patient-Reported Outcomes in a Pivotal Clinical Study of Hyperphosphatemia: Oxylanthanum Carbonate Reduces Pill Burden by Half and Improves Adherence\"  on Thursday, April 10, from 5:15–7:30 p.m. ET.OLC improved adherence – 70% of patients reported consistent a","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/unicycive-presents-patient-level-data-120000738.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0170899867.USD","LU0882574139.USD","IE00BHPRN162.USD","CMC","IE00BKVL7J92.USD","IE00BZ1G4Q59.USD","BK4006","IE00B1BXHZ80.USD","LU0149725797.USD","BK4139","BK4539","LU1363072403.SGD","UNCY","LU0971096721.USD","LU0267386448.USD"],"gpt_icon":0},{"id":"2524195075","title":"Unicycive Therapeutics, Inc. : H.c. Wainwright Raises Target Price to $7.5 From $4","url":"https://stock-news.laohu8.com/highlight/detail?id=2524195075","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524195075?lang=en_us&edition=fundamental","pubTime":"2025-04-01 18:15","pubTimestamp":1743502519,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250401:nAZN3N4EAW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["UNCY","BK4539","BK4139"],"gpt_icon":0},{"id":"2523107649","title":"Unicycive Therapeutics reports FY24 EPS (56c), consensus (51c)","url":"https://stock-news.laohu8.com/highlight/detail?id=2523107649","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523107649?lang=en_us&edition=fundamental","pubTime":"2025-03-31 19:17","pubTimestamp":1743419847,"startTime":"0","endTime":"0","summary":"“2025 is positioned to be a transformational year for Unicycive, with the near-term potential for FDA approval and commercial launch of oxylanthanu...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/unicycive-therapeutics-reports-fy24-eps-56c-consensus-51c?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/unicycive-therapeutics-reports-fy24-eps-56c-consensus-51c?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LENZ","UNCY"],"gpt_icon":0},{"id":"2523917995","title":"Unicycive Therapeutics Inc: Believes That It Has Sufficient Resources to Fund Planned Operations Into 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2523917995","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523917995?lang=en_us&edition=fundamental","pubTime":"2025-03-31 19:05","pubTimestamp":1743419142,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250331:nFWN3QE0UO:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BK4539","UNCY"],"gpt_icon":0},{"id":"2523650917","title":"Unicycive Therapeutics FY 2024 GAAP EPS $(0.56) Misses $(0.50) Estimate, As Of December 31, 2024, Cash And Cash Equivalents Of $26.1M, Sufficient To Fund Planned Operations Into 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2523650917","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523650917?lang=en_us&edition=fundamental","pubTime":"2025-03-31 19:04","pubTimestamp":1743419079,"startTime":"0","endTime":"0","summary":"Unicycive Therapeutics (NASDAQ:UNCY) reported quarterly losses of $(0.56) per share which missed the analyst consensus estimate of $(0.50) by 12 percent. This is a 56.25 percent increase over losses of $(1.28) per share","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/03/44558190/unicycive-therapeutics-fy-2024-gaap-eps-0-56-misses-0-50-estimate-as-of-december-31-2024-cash-and-c","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","UNCY"],"gpt_icon":0},{"id":"2523176869","title":"Unicycive Therapeutics Announces Full Year 2024 Financial Results and Provides Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2523176869","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523176869?lang=en_us&edition=fundamental","pubTime":"2025-03-31 19:00","pubTimestamp":1743418800,"startTime":"0","endTime":"0","summary":"-Oxylanthanum carbonate  New Drug Application for hyperphosphatemia in chronic kidney disease patients on dialysis under review by the FDA with a PDUFA target action date of June 28, 2025. - Commercial planning in preparation for anticipated commercial launch of OLC in late 2025. Announced the acceptance of the New Drug Application  by theU.S. Food and Drug Administration  for OLC for the treatment of hyperphosphatemia in patients with CKD on dialysis. The FDA set a Prescription Drug User Fee Act  target action date of June 28, 2025.Continued efforts to establish an efficient commercial infrastructure, including building key functions, engaging directly with prescribers and other stakeholders and preparing to support market access are ongoing. Expanded awareness of OLC and its potential to address significant needs for CKD patients through publication of data, including in the peer-reviewed journals Clinical Therapeutics, Clinical and Translational Science, and Journal of Nephrological","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/unicycive-therapeutics-announces-full-2024-110000395.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LENZ","BK4139","BK4539","UNCY"],"gpt_icon":0},{"id":"2522329609","title":"Calendar of U.S. Earnings Expected in the Week Ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=2522329609","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522329609?lang=en_us&edition=fundamental","pubTime":"2025-03-27 18:00","pubTimestamp":1743069600,"startTime":"0","endTime":"0","summary":"Major companies tentatively scheduled to report quarterly earnings in the week ahead, with earnings estimates provided by FactSet Research Systems Inc.·INmune Bio Inc.                                 4Q      (.55)  4:05 PM. ·TD SYNNEX Corp                                   1Q      2.91   8:05 AM","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RANI","FC","BLRX","RLMD","FEMY","LNZA","PRGS","GEVO","TSAT","KYTX","ATAI","NNOX","DARE","CRDL","BW","GOVX","PVLA","REKR","UNCY","WGO","WBA","SGML","BCAB","SLRN","SPWH","TLSI","CELC","FTCI","BRZE","NUTX","BHST","EDAP","CLSD","CALC","LULU","AFMD","NCNO","IKT","INMB","MDAI","PVH","SKYH","INR","ADCT","GWH","ANGO","PENG","SDST","FBIO","WKSP"],"gpt_icon":0},{"id":"2522336280","title":"DaVita Stock Declines 1.2% in 3 Months: Here's How to Play","url":"https://stock-news.laohu8.com/highlight/detail?id=2522336280","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522336280?lang=en_us&edition=fundamental","pubTime":"2025-03-26 23:59","pubTimestamp":1743004740,"startTime":"0","endTime":"0","summary":"DaVita Inc.’s DVA investors have been experiencing some short-term losses of late. Shares of this Denver, CO-based comprehensive kidney care provider have lost 1.2% in the past three months in contrast to the industry and the sector’s 2.6% and 1.1% gains, respectively. The stock has, however, outperformed the S&P 500’s 3.6% decline.A major development at DVA in recent months was the announcement of its promising fourth-quarter 2024 results in February. The company reported robust improvement in the top and bottom lines in the fourth quarter of 2024. Strength in segmental revenues during the quarter was also recorded. On the earnings call, management confirmed that within U.S. dialysis, DVA continued to benefit from innovation in its revenue cycle operations. Enhanced collection performance and contracting propelled higher revenue per treatment growth during the quarter.However, the per-day decrease in total U.S. dialysis treatments for the fourth quarter on a sequential basis and the y","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/davita-stock-declines-1-2-155900368.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["FMS","UNCY","BK4139","BK4196","BK4588","DVA","BK4539","BK4585","BK4559"],"gpt_icon":0},{"id":"2521714099","title":"Calendar of U.S. Earnings Expected in the Week Ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=2521714099","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521714099?lang=en_us&edition=fundamental","pubTime":"2025-03-24 18:00","pubTimestamp":1742810400,"startTime":"0","endTime":"0","summary":"Major companies tentatively scheduled to report quarterly earnings in the week ahead, with earnings estimates provided by FactSet Research Systems Inc.·Comp de San Bas                                  4Q       .36       AMC. ·Oklo Inc. Class A                               4Q      (.07)      AMC. ·Core & Main Inc.                                 4Q       .36       BMO. ·McCormick & Co                                 1Q       .64   6:30 AM","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SCS","PDSB","PAYX","UNCY","WBA","LPTX","CNXC","WOOF","MDAI","SURG","IVA","ANTX","NUTX","SKYX","AFMD","CDLR","KOD","DLTR","RLMD","BCAB","SDST","TEN","OBIO","ALUR","IOBT","ACRV","DERM","EDAP","MKC","WGO","KBH","THRD","PAYS","IKT","RVPH","BEEM","ZURA","CLSD","XFOR","GRDN","CALC","FBIO","SLRN","GOVX","ABL","CHWY","MREO","MLKN","CTAS","CRMD"],"gpt_icon":0},{"id":"2519887618","title":"Unicycive to Highlight Patient Reported Outcomes Data at Upcoming Medical Meetings Showing Oxylanthanum Carbonate Reduced Pill Burden and Improved Adherence in Treatment of Hyperphosphatemia","url":"https://stock-news.laohu8.com/highlight/detail?id=2519887618","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519887618?lang=en_us&edition=fundamental","pubTime":"2025-03-13 19:00","pubTimestamp":1741863602,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250313:nTUABVJDCC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["UNCY","BK4139","BK4539"],"gpt_icon":0},{"id":"2513995212","title":"Noble Financial Sticks to Its Buy Rating for Unicycive Therapeutics (UNCY)","url":"https://stock-news.laohu8.com/highlight/detail?id=2513995212","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513995212?lang=en_us&edition=fundamental","pubTime":"2025-02-21 22:55","pubTimestamp":1740149721,"startTime":"0","endTime":"0","summary":"Noble Financial analyst Robert LeBoyer reiterated a Buy rating on Unicycive Therapeutics (UNCY – Research Report) today and set a price target of $...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/noble-financial-sticks-to-its-buy-rating-for-unicycive-therapeutics-uncy?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/noble-financial-sticks-to-its-buy-rating-for-unicycive-therapeutics-uncy?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["UNCY","NBL"],"gpt_icon":0},{"id":"2512462434","title":"Unicycive Therapeutics Announces the Publication of Preclinical Data on Synergies Between Oxylanthanum Carbonate and Tenapanor in American Society of Nephrology Journal Kidney360","url":"https://stock-news.laohu8.com/highlight/detail?id=2512462434","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512462434?lang=en_us&edition=fundamental","pubTime":"2025-02-20 20:00","pubTimestamp":1740052800,"startTime":"0","endTime":"0","summary":"Combination therapy with oxylanthanum carbonate plus tenapanor led to greater reductions in urinary phosphate excretion than either drug alone. LOS ALTOS, Calif., Feb. 20, 2025  -- Unicycive Therapeutics, Inc., a clinical-stage biotechnology company developing therapies for patients with kidney disease, today announced the publication of preclinical data describing the benefits of combination treatment of oxylanthanum carbonate  and tenapanor on phosphate management in the American Society of Nephrology  journal, Kidney360.The publication, entitled “Combination Oxylanthanum Carbonate and Tenapanor Lowers Urinary Phosphate Excretion in Rats,” examines the potential synergistic benefits of a combination of OLC, a phosphate binder, with tenapanor, a sodium/hydrogen exchanger 3  inhibitor, on urinary phosphate excretion. Data demonstrated sizeable reductions in urinary phosphate excretion  in response to both OLC monotherapy and the combination of OLC with tenapanor.A pooled analysis of mo","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/unicycive-therapeutics-announces-publication-preclinical-120000211.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4539","IE00BKVL7J92.USD","BK4117","LENZ","LU0149725797.USD","BK4139","LU0882574139.USD","IE00B1BXHZ80.USD","BK4006","IE00BHPRN162.USD","LU0267386448.USD","LU0971096721.USD","LU0170899867.USD","IE00BZ1G4Q59.USD","CMC","LU1363072403.SGD","BK4107","AFG","UNCY"],"gpt_icon":0},{"id":"2507687761","title":"Unicycive Therapeutics Price Target Maintained With a $4.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2507687761","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2507687761?lang=en_us&edition=fundamental","pubTime":"2025-01-29 20:23","pubTimestamp":1738153380,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/UNCY/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  January 29, 2025 07:23 ET (12:23 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","UNCY"],"gpt_icon":0},{"id":"2507684837","title":"Buy Rating for Unicycive Therapeutics Driven by Promising OLC Treatment and Reduced Pill Burden","url":"https://stock-news.laohu8.com/highlight/detail?id=2507684837","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2507684837?lang=en_us&edition=fundamental","pubTime":"2025-01-29 19:25","pubTimestamp":1738149942,"startTime":"0","endTime":"0","summary":"In a report released today, Ed Arce from H.C. Wainwright maintained a Buy rating on Unicycive Therapeutics (UNCY – Research Report), with a price t...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/buy-rating-for-unicycive-therapeutics-driven-by-promising-olc-treatment-and-reduced-pill-burden?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/buy-rating-for-unicycive-therapeutics-driven-by-promising-olc-treatment-and-reduced-pill-burden?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LENZ","UNCY"],"gpt_icon":0},{"id":"2506970125","title":"Unicycive announces publication of patient perspectives on phosphate management","url":"https://stock-news.laohu8.com/highlight/detail?id=2506970125","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2506970125?lang=en_us&edition=fundamental","pubTime":"2025-01-28 20:17","pubTimestamp":1738066624,"startTime":"0","endTime":"0","summary":"Unicycive Therapeutics (UNCY) announced the publication of a review on patient perspectives regarding phosphate management in the peer-reviewed jou...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/unicycive-announces-publication-of-patient-perspectives-on-phosphate-management?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/unicycive-announces-publication-of-patient-perspectives-on-phosphate-management?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","UNCY","BK4139"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":43,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/UNCY\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-03-31","symbol":"UNCY","fiscalQuarterEnding":"2024/12","expectedEps":-0.13,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1743393600000,"reportTimeType":"pre","actualEps":-0.26},{"market":"US","date":"2021-08-16","symbol":"UNCY","fiscalQuarterEnding":"2021/06","expectedEps":-0.11,"name":null,"time":"","type":"earning","dateTimestamp":1629086400000,"reportTimeType":"","actualEps":-0.13}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"UNCY\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"UNCY\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.1429,"buy":0.8571,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.8571,"analysts":7,"updateTime":1745294400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/UNCY\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"UNCY","date":"2025-04-30","current":-2.098887,"percent":0.313767,"low":-38.78456,"twenty":-2.827981,"median":-1.370824,"eighty":-0.696598,"high":-0.240311,"avg":-2.811272,"sd":4.45504,"marketCap":77090036},"quantilePoints":[{"date":"2021-06-17","current":-38.78456,"twenty":-38.78456,"median":-38.78456,"eighty":-38.78456,"marketCap":111854672},{"date":"2021-06-24","current":-33.408445,"twenty":-38.78456,"median":-36.096502,"eighty":-33.408445,"marketCap":96349956},{"date":"2021-07-09","current":-26.661885,"twenty":-38.78456,"median":-30.035165,"eighty":-25.132216,"marketCap":76892876},{"date":"2021-07-16","current":-15.512369,"twenty":-34.483668,"median":-26.661885,"eighty":-18.362768,"marketCap":44737673},{"date":"2021-07-23","current":-14.445894,"twenty":-33.408445,"median":-22.837713,"eighty":-14.319856,"marketCap":41661958},{"date":"2021-07-30","current":-13.379419,"twenty":-29.368529,"median":-18.130082,"eighty":-13.815704,"marketCap":38586243},{"date":"2021-08-06","current":-12.846181,"twenty":-27.001218,"median":-15.100322,"eighty":-13.350333,"marketCap":37048385},{"date":"2021-08-13","current":-13.23399,"twenty":-26.661885,"median":-14.445894,"eighty":-13.350333,"marketCap":38166827},{"date":"2021-08-20","current":-10.38564,"twenty":-26.661885,"median":-13.961132,"eighty":-13.001304,"marketCap":37866044},{"date":"2021-08-27","current":-10.982516,"twenty":-26.661885,"median":-13.815704,"eighty":-10.950683,"marketCap":40042253},{"date":"2021-09-03","current":-10.863141,"twenty":-20.543211,"median":-13.646037,"eighty":-10.855183,"marketCap":39607011},{"date":"2021-09-10","current":-11.658975,"twenty":-18.65798,"median":-13.476371,"eighty":-10.934766,"marketCap":42508624},{"date":"2021-09-17","current":-11.181475,"twenty":-18.246425,"median":-13.23399,"eighty":-11.006391,"marketCap":40767657},{"date":"2021-09-24","current":-11.420225,"twenty":-17.279605,"median":-12.943133,"eighty":-10.887016,"marketCap":41638140},{"date":"2021-10-01","current":-11.460017,"twenty":-15.99247,"median":-12.846181,"eighty":-10.902933,"marketCap":41783221},{"date":"2021-10-08","current":-10.624391,"twenty":-15.076084,"median":-11.57402,"eighty":-10.902933,"marketCap":38736528},{"date":"2021-10-15","current":-10.84046,"twenty":-14.727056,"median":-11.499809,"eighty":-10.833616,"marketCap":39524316},{"date":"2021-10-22","current":-10.107098,"twenty":-14.542846,"median":-11.440121,"eighty":-10.664182,"marketCap":36850480},{"date":"2021-10-29","current":-11.499809,"twenty":-14.416808,"median":-11.460017,"eighty":-10.664182,"marketCap":41928302},{"date":"2021-11-05","current":-11.738559,"twenty":-14.222904,"median":-11.499809,"eighty":-10.688057,"marketCap":42798785},{"date":"2021-11-12","current":-4.981659,"twenty":-13.932047,"median":-11.460017,"eighty":-10.688057,"marketCap":40575615},{"date":"2021-11-19","current":-4.761069,"twenty":-13.815704,"median":-11.400329,"eighty":-10.576641,"marketCap":38778909},{"date":"2021-11-26","current":-5.367692,"twenty":-13.815704,"median":-11.340642,"eighty":-10.441349,"marketCap":43719851},{"date":"2021-12-03","current":-3.327234,"twenty":-13.796314,"median":-11.30085,"eighty":-10.33789,"marketCap":27100319},{"date":"2021-12-10","current":-4.025769,"twenty":-13.728447,"median":-11.221267,"eighty":-10.162807,"marketCap":32789888},{"date":"2021-12-17","current":-3.952239,"twenty":-13.650885,"median":-11.181475,"eighty":-7.295421,"marketCap":32190986},{"date":"2021-12-23","current":-3.841944,"twenty":-13.612104,"median":-11.0621,"eighty":-5.088278,"marketCap":31292633},{"date":"2021-12-31","current":-3.786796,"twenty":-13.534542,"median":-10.982516,"eighty":-4.786805,"marketCap":30843457},{"date":"2022-01-07","current":-3.382381,"twenty":-13.350333,"median":-10.942724,"eighty":-4.268271,"marketCap":27549495},{"date":"2022-01-14","current":-3.290469,"twenty":-13.23399,"median":-10.922829,"eighty":-3.937533,"marketCap":26800868},{"date":"2022-01-21","current":-3.106644,"twenty":-13.23399,"median":-10.902933,"eighty":-3.860326,"marketCap":25303612},{"date":"2022-01-28","current":-2.63789,"twenty":-13.088562,"median":-10.84046,"eighty":-3.805179,"marketCap":21485612},{"date":"2022-02-04","current":-2.500021,"twenty":-13.040085,"median":-10.72387,"eighty":-3.685693,"marketCap":20362670},{"date":"2022-02-11","current":-2.408108,"twenty":-12.846181,"median":-10.664182,"eighty":-3.547824,"marketCap":19614043},{"date":"2022-02-18","current":-2.500021,"twenty":-12.846181,"median":-10.564703,"eighty":-3.437529,"marketCap":20362670},{"date":"2022-02-25","current":-2.389726,"twenty":-12.846181,"median":-10.465224,"eighty":-3.375028,"marketCap":19464317},{"date":"2022-03-04","current":-2.647081,"twenty":-12.278417,"median":-10.425432,"eighty":-3.308851,"marketCap":21560474},{"date":"2022-03-11","current":-2.408108,"twenty":-12.104642,"median":-10.345848,"eighty":-3.224292,"marketCap":19614043},{"date":"2022-03-18","current":-2.077223,"twenty":-12.06485,"median":-10.186682,"eighty":-3.033114,"marketCap":16918983},{"date":"2022-03-25","current":-2.297813,"twenty":-11.834059,"median":-10.126994,"eighty":-2.661787,"marketCap":18715690},{"date":"2022-04-01","current":-1.946241,"twenty":-11.746517,"median":-9.828556,"eighty":-2.606639,"marketCap":19495494},{"date":"2022-04-08","current":-1.916299,"twenty":-11.706725,"median":-5.330927,"eighty":-2.573551,"marketCap":19195563},{"date":"2022-04-14","current":-1.616877,"twenty":-11.674892,"median":-5.009233,"eighty":-2.547815,"marketCap":16196256},{"date":"2022-04-22","current":-1.664448,"twenty":-11.611225,"median":-4.889747,"eighty":-2.51105,"marketCap":16672773},{"date":"2022-04-29","current":-1.305617,"twenty":-11.572946,"median":-4.669156,"eighty":-2.481638,"marketCap":13078364},{"date":"2022-05-06","current":-1.285374,"twenty":-11.551219,"median":-4.191028,"eighty":-2.43752,"marketCap":12875587},{"date":"2022-05-13","current":-0.83558,"twenty":-11.5396,"median":-3.989004,"eighty":-2.408108,"marketCap":10519957},{"date":"2022-05-20","current":-0.943012,"twenty":-11.515725,"median":-3.878709,"eighty":-2.389726,"marketCap":11872523},{"date":"2022-05-27","current":-1.014633,"twenty":-11.499809,"median":-3.851135,"eighty":-2.297813,"marketCap":12774234},{"date":"2022-06-03","current":-1.002697,"twenty":-11.499809,"median":-3.805179,"eighty":-2.055164,"marketCap":12623949},{"date":"2022-06-10","current":-1.265307,"twenty":-11.483892,"median":-3.786796,"eighty":-1.954516,"marketCap":15930221},{"date":"2022-06-17","current":-1.145819,"twenty":-11.460017,"median":-3.717862,"eighty":-1.901328,"marketCap":14425867},{"date":"2022-06-24","current":-0.993744,"twenty":-11.452059,"median":-3.658119,"eighty":-1.696853,"marketCap":12511235},{"date":"2022-07-01","current":-0.978823,"twenty":-11.412267,"median":-3.547824,"eighty":-1.620393,"marketCap":12323379},{"date":"2022-07-08","current":-1.074318,"twenty":-11.380433,"median":-3.492676,"eighty":-1.556993,"marketCap":13525659},{"date":"2022-07-15","current":-0.955546,"twenty":-11.340642,"median":-3.423742,"eighty":-1.370095,"marketCap":12030323},{"date":"2022-07-22","current":-0.954949,"twenty":-11.340642,"median":-3.382381,"eighty":-1.305617,"marketCap":12022808},{"date":"2022-07-29","current":-0.883328,"twenty":-11.30085,"median":-3.327234,"eighty":-1.265307,"marketCap":11121098},{"date":"2022-08-05","current":-0.883328,"twenty":-11.30085,"median":-3.308851,"eighty":-1.205623,"marketCap":11121098},{"date":"2022-08-12","current":-0.871152,"twenty":-11.261058,"median":-3.244512,"eighty":-1.169813,"marketCap":10967807},{"date":"2022-08-19","current":-0.696699,"twenty":-11.261058,"median":-3.161791,"eighty":-1.086255,"marketCap":10538265},{"date":"2022-08-26","current":-0.696598,"twenty":-11.181475,"median":-3.00554,"eighty":-1.069661,"marketCap":10536745},{"date":"2022-09-02","current":-0.667839,"twenty":-11.181475,"median":-2.702228,"eighty":-1.049608,"marketCap":10101728},{"date":"2022-09-09","current":-0.723965,"twenty":-11.181475,"median":-2.647081,"eighty":-1.030199,"marketCap":10950688},{"date":"2022-09-16","current":-0.676695,"twenty":-11.117808,"median":-2.619507,"eighty":-1.014633,"marketCap":10235695},{"date":"2022-09-23","current":-0.56524,"twenty":-11.070058,"median":-2.573551,"eighty":-1.002697,"marketCap":8549816},{"date":"2022-09-30","current":-0.587133,"twenty":-11.030266,"median":-2.573551,"eighty":-0.99076,"marketCap":8880970},{"date":"2022-10-07","current":-0.616987,"twenty":-10.990474,"median":-2.555168,"eighty":-0.978823,"marketCap":9332545},{"date":"2022-10-14","current":-0.56713,"twenty":-10.982516,"median":-2.527595,"eighty":-0.956978,"marketCap":8578415},{"date":"2022-10-21","current":-0.656692,"twenty":-10.950682,"median":-2.500021,"eighty":-0.95187,"marketCap":9933125},{"date":"2022-10-28","current":-0.676695,"twenty":-10.942724,"median":-2.490829,"eighty":-0.900135,"marketCap":10235695},{"date":"2022-11-04","current":-0.766258,"twenty":-10.942724,"median":-2.481638,"eighty":-0.886193,"marketCap":11590419},{"date":"2022-11-11","current":-0.711525,"twenty":-10.942724,"median":-2.435682,"eighty":-0.883328,"marketCap":10762532},{"date":"2022-11-18","current":-0.7212,"twenty":-10.910891,"median":-2.426491,"eighty":-0.855348,"marketCap":11165615},{"date":"2022-11-25","current":-0.653076,"twenty":-10.902933,"median":-2.408108,"eighty":-0.775731,"marketCap":10110917},{"date":"2022-12-02","current":-0.682216,"twenty":-10.902933,"median":-2.398917,"eighty":-0.744252,"marketCap":10562069},{"date":"2022-12-09","current":-0.728899,"twenty":-10.879058,"median":-2.371343,"eighty":-0.721366,"marketCap":11284816},{"date":"2022-12-16","current":-0.691962,"twenty":-10.849532,"median":-2.297813,"eighty":-0.716501,"marketCap":10712955},{"date":"2022-12-23","current":-0.671495,"twenty":-10.830193,"median":-2.077223,"eighty":-0.711497,"marketCap":10396093},{"date":"2022-12-30","current":-0.526281,"twenty":-10.791516,"median":-2.003693,"eighty":-0.709115,"marketCap":8147881},{"date":"2023-01-06","current":-0.436033,"twenty":-10.735808,"median":-1.966928,"eighty":-0.706776,"marketCap":6750670},{"date":"2023-01-13","current":-0.484861,"twenty":-10.696016,"median":-1.923785,"eighty":-0.697721,"marketCap":7506613},{"date":"2023-01-20","current":-0.563466,"twenty":-10.664182,"median":-1.901328,"eighty":-0.696598,"marketCap":8723574},{"date":"2023-01-27","current":-0.545773,"twenty":-10.664182,"median":-1.826472,"eighty":-0.694106,"marketCap":8449655},{"date":"2023-02-03","current":-0.514293,"twenty":-10.664182,"median":-1.649453,"eighty":-0.687089,"marketCap":7962291},{"date":"2023-02-10","current":-0.536027,"twenty":-10.624391,"median":-1.616877,"eighty":-0.686647,"marketCap":8298768},{"date":"2023-02-17","current":-0.516535,"twenty":-10.505015,"median":-1.579306,"eighty":-0.68396,"marketCap":7996995},{"date":"2023-02-24","current":-0.467805,"twenty":-10.473182,"median":-1.512676,"eighty":-0.680968,"marketCap":7242561},{"date":"2023-03-03","current":-0.477551,"twenty":-10.465224,"median":-1.370095,"eighty":-0.676695,"marketCap":7393448},{"date":"2023-03-10","current":-2.611913,"twenty":-10.43339,"median":-1.465627,"eighty":-0.676695,"marketCap":40437635},{"date":"2023-03-17","current":-2.036902,"twenty":-10.425432,"median":-1.52705,"eighty":-0.67773,"marketCap":31535320},{"date":"2023-03-24","current":-1.861475,"twenty":-10.393598,"median":-1.590231,"eighty":-0.678252,"marketCap":28819359},{"date":"2023-03-31","current":-2.046648,"twenty":-10.38564,"median":-1.616877,"eighty":-0.680968,"marketCap":31686207},{"date":"2023-04-06","current":-1.779758,"twenty":-10.33789,"median":-1.634458,"eighty":-0.681982,"marketCap":32138867},{"date":"2023-04-14","current":-1.56251,"twenty":-10.282182,"median":-1.645634,"eighty":-0.682216,"marketCap":28215812},{"date":"2023-04-21","current":-1.358206,"twenty":-10.218515,"median":-1.616877,"eighty":-0.683262,"marketCap":24526475},{"date":"2023-04-28","current":-1.121996,"twenty":-10.186682,"median":-1.590231,"eighty":-0.684199,"marketCap":20261001},{"date":"2023-05-05","current":-1.11356,"twenty":-10.162807,"median":-1.56251,"eighty":-0.685731,"marketCap":20108663},{"date":"2023-05-12","current":-1.240101,"twenty":-10.123015,"median":-1.512676,"eighty":-0.686647,"marketCap":22393738},{"date":"2023-05-19","current":-0.727764,"twenty":-10.083223,"median":-1.47631,"eighty":-0.686647,"marketCap":21175032},{"date":"2023-05-26","current":-0.751325,"twenty":-9.924056,"median":-1.456447,"eighty":-0.686647,"marketCap":21860554},{"date":"2023-06-02","current":-0.727764,"twenty":-8.1398,"median":-1.408822,"eighty":-0.686785,"marketCap":21175032},{"date":"2023-06-09","current":-0.811536,"twenty":-5.511076,"median":-1.358206,"eighty":-0.687031,"marketCap":23612445},{"date":"2023-06-16","current":-0.827243,"twenty":-5.33828,"median":-1.322011,"eighty":-0.687089,"marketCap":24069460},{"date":"2023-06-23","current":-0.785357,"twenty":-5.242691,"median":-1.312289,"eighty":-0.687239,"marketCap":22850754},{"date":"2023-06-30","current":-0.863893,"twenty":-5.036807,"median":-1.283828,"eighty":-0.687841,"marketCap":25135829},{"date":"2023-07-07","current":-0.607343,"twenty":-4.992689,"median":-1.273742,"eighty":-0.686923,"marketCap":17671249},{"date":"2023-07-14","current":-0.649229,"twenty":-4.981659,"median":-1.265307,"eighty":-0.686493,"marketCap":18889956},{"date":"2023-07-21","current":-0.654464,"twenty":-4.908129,"median":-1.250954,"eighty":-0.682216,"marketCap":19042295},{"date":"2023-07-28","current":-0.617814,"twenty":-4.786805,"median":-1.240101,"eighty":-0.67773,"marketCap":17975926},{"date":"2023-08-04","current":-0.607343,"twenty":-4.716951,"median":-1.208497,"eighty":-0.676695,"marketCap":17671249},{"date":"2023-08-11","current":-0.471214,"twenty":-4.66548,"median":-1.190557,"eighty":-0.672022,"marketCap":13710452},{"date":"2023-08-18","current":-0.952727,"twenty":-4.606656,"median":-1.169813,"eighty":-0.671371,"marketCap":27912983},{"date":"2023-08-25","current":-0.91216,"twenty":-4.345514,"median":-1.146562,"eighty":-0.672022,"marketCap":26724457},{"date":"2023-09-01","current":-0.904924,"twenty":-4.169079,"median":-1.122065,"eighty":-0.672431,"marketCap":26512469},{"date":"2023-09-08","current":-0.924021,"twenty":-4.102976,"median":-1.11356,"eighty":-0.673645,"marketCap":27071980},{"date":"2023-09-15","current":-0.831501,"twenty":-3.996357,"median":-1.087627,"eighty":-0.675922,"marketCap":24361306},{"date":"2023-09-22","current":-0.782868,"twenty":-3.948562,"median":-1.080517,"eighty":-0.676695,"marketCap":22936465},{"date":"2023-09-29","current":-1.079409,"twenty":-3.922827,"median":-1.074318,"eighty":-0.676695,"marketCap":31624521},{"date":"2023-10-06","current":-1.031962,"twenty":-3.875032,"median":-1.07052,"eighty":-0.676695,"marketCap":30234432},{"date":"2023-10-13","current":-1.004681,"twenty":-3.860326,"median":-1.062943,"eighty":-0.676954,"marketCap":29435131},{"date":"2023-10-20","current":-1.055567,"twenty":-3.85665,"median":-1.055626,"eighty":-0.678055,"marketCap":30926001},{"date":"2023-10-27","current":-0.729491,"twenty":-3.849297,"median":-1.053847,"eighty":-0.678186,"marketCap":21372615},{"date":"2023-11-03","current":-0.693906,"twenty":-3.819885,"median":-1.049608,"eighty":-0.677471,"marketCap":20330049},{"date":"2023-11-10","current":-0.678367,"twenty":-3.805179,"median":-1.038298,"eighty":-0.678186,"marketCap":19874795},{"date":"2023-11-17","current":-0.63528,"twenty":-3.805179,"median":-1.031725,"eighty":-0.676695,"marketCap":17834839},{"date":"2023-11-24","current":-0.74884,"twenty":-3.797826,"median":-1.02657,"eighty":-0.676559,"marketCap":21022937},{"date":"2023-12-01","current":-0.62195,"twenty":-3.779443,"median":-1.022858,"eighty":-0.673645,"marketCap":17460611},{"date":"2023-12-08","current":-0.718015,"twenty":-3.761061,"median":-1.014633,"eighty":-0.671846,"marketCap":20157552},{"date":"2023-12-15","current":-0.718015,"twenty":-3.724296,"median":-1.011828,"eighty":-0.672412,"marketCap":20157552},{"date":"2023-12-22","current":-0.705635,"twenty":-3.685693,"median":-1.004681,"eighty":-0.67247,"marketCap":19810008},{"date":"2023-12-29","current":-1.083088,"twenty":-3.680178,"median":-1.003689,"eighty":-0.674232,"marketCap":30406625},{"date":"2024-01-05","current":-1.02738,"twenty":-3.669148,"median":-1.009023,"eighty":-0.675619,"marketCap":28842677},{"date":"2024-01-12","current":-1.107971,"twenty":-3.63606,"median":-1.014633,"eighty":-0.676514,"marketCap":31105188},{"date":"2024-01-19","current":-1.064271,"twenty":-3.621354,"median":-1.018914,"eighty":-0.676695,"marketCap":29878358},{"date":"2024-01-26","current":-1.1513,"twenty":-3.547824,"median":-1.02657,"eighty":-0.676695,"marketCap":32321592},{"date":"2024-02-02","current":-1.188439,"twenty":-3.547824,"median":-1.028061,"eighty":-0.676695,"marketCap":33364224},{"date":"2024-02-09","current":-1.411271,"twenty":-3.492676,"median":-1.031725,"eighty":-0.676695,"marketCap":39620017},{"date":"2024-02-16","current":-1.621723,"twenty":-3.492676,"median":-1.038298,"eighty":-0.677989,"marketCap":45528265},{"date":"2024-02-23","current":-2.166424,"twenty":-3.448558,"median":-1.039884,"eighty":-0.678252,"marketCap":60820201},{"date":"2024-03-01","current":-1.70838,"twenty":-3.41547,"median":-1.049608,"eighty":-0.678357,"marketCap":47961073},{"date":"2024-03-08","current":-1.856935,"twenty":-3.387896,"median":-1.052195,"eighty":-0.680374,"marketCap":52131601},{"date":"2024-03-15","current":-1.782658,"twenty":-3.382381,"median":-1.055686,"eighty":-0.68148,"marketCap":50046337},{"date":"2024-03-22","current":-1.646483,"twenty":-3.352969,"median":-1.063607,"eighty":-0.682099,"marketCap":46223353},{"date":"2024-03-28","current":-1.807417,"twenty":-3.334587,"median":-1.067154,"eighty":-0.682216,"marketCap":50741425},{"date":"2024-04-05","current":-1.661354,"twenty":-3.327234,"median":-1.07269,"eighty":-0.683262,"marketCap":50744396},{"date":"2024-04-12","current":-1.422392,"twenty":-3.316204,"median":-1.079601,"eighty":-0.684199,"marketCap":43445545},{"date":"2024-04-19","current":-1.240326,"twenty":-3.308851,"median":-1.083088,"eighty":-0.685271,"marketCap":37884515},{"date":"2024-04-26","current":-1.103776,"twenty":-3.297822,"median":-1.087627,"eighty":-0.68634,"marketCap":33713742},{"date":"2024-05-03","current":-1.378968,"twenty":-3.26841,"median":-1.095716,"eighty":-0.686647,"marketCap":42119208},{"date":"2024-05-10","current":-1.329719,"twenty":-3.242674,"median":-1.099235,"eighty":-0.686647,"marketCap":40614950},{"date":"2024-05-17","current":-1.048809,"twenty":-3.202233,"median":-1.101782,"eighty":-0.686647,"marketCap":38734629},{"date":"2024-05-24","current":-0.986186,"twenty":-3.169144,"median":-1.096573,"eighty":-0.686854,"marketCap":36421833},{"date":"2024-05-31","current":-0.852086,"twenty":-3.139732,"median":-1.093434,"eighty":-0.687031,"marketCap":31469227},{"date":"2024-06-07","current":-0.784065,"twenty":-3.084585,"median":-1.086255,"eighty":-0.687089,"marketCap":28957105},{"date":"2024-06-14","current":-0.666965,"twenty":-3.033114,"median":-1.083088,"eighty":-0.686716,"marketCap":24632342},{"date":"2024-06-21","current":-0.641508,"twenty":-2.959584,"median":-1.079793,"eighty":-0.686647,"marketCap":23692176},{"date":"2024-06-28","current":-0.4125,"twenty":-2.893407,"median":-1.079409,"eighty":-0.684966,"marketCap":15234445},{"date":"2024-07-05","current":-0.498951,"twenty":-2.775758,"median":-1.074318,"eighty":-0.682216,"marketCap":18427248},{"date":"2024-07-12","current":-0.488768,"twenty":-2.694875,"median":-1.07052,"eighty":-0.678328,"marketCap":18051182},{"date":"2024-07-15","current":-0.50394,"twenty":-2.687522,"median":-1.069661,"eighty":-0.678121,"marketCap":18611521},{"date":"2024-08-02","current":-0.434494,"twenty":-2.680169,"median":-1.067154,"eighty":-0.677471,"marketCap":16046749},{"date":"2024-08-09","current":-0.370445,"twenty":-2.654434,"median":-1.062943,"eighty":-0.676605,"marketCap":13681291},{"date":"2024-08-16","current":-0.485477,"twenty":-2.641566,"median":-1.058992,"eighty":-0.672463,"marketCap":11281989},{"date":"2024-08-23","current":-1.542896,"twenty":-2.632375,"median":-1.062381,"eighty":-0.672463,"marketCap":35855360},{"date":"2024-08-30","current":-1.391855,"twenty":-2.618627,"median":-1.064459,"eighty":-0.672467,"marketCap":32345309},{"date":"2024-09-06","current":-1.434487,"twenty":-2.611274,"median":-1.07052,"eighty":-0.673645,"marketCap":33336049},{"date":"2024-09-13","current":-1.542896,"twenty":-2.602963,"median":-1.074318,"eighty":-0.675832,"marketCap":35855360},{"date":"2024-09-20","current":-1.745909,"twenty":-2.58458,"median":-1.079601,"eighty":-0.676559,"marketCap":40573171},{"date":"2024-09-27","current":-1.66511,"twenty":-2.573551,"median":-1.083088,"eighty":-0.676695,"marketCap":38695482},{"date":"2024-10-04","current":-1.542896,"twenty":-2.573551,"median":-1.087627,"eighty":-0.676695,"marketCap":35855360},{"date":"2024-10-11","current":-1.456819,"twenty":-2.573551,"median":-1.095716,"eighty":-0.676695,"marketCap":33855008},{"date":"2024-10-18","current":-1.847009,"twenty":-2.566198,"median":-1.098205,"eighty":-0.677213,"marketCap":42922640},{"date":"2024-10-25","current":-1.695968,"twenty":-2.555168,"median":-1.103776,"eighty":-0.678121,"marketCap":39412589},{"date":"2024-10-31","current":-2.070729,"twenty":-2.551492,"median":-1.109905,"eighty":-0.678328,"marketCap":48121668},{"date":"2024-11-08","current":-2.313532,"twenty":-2.536786,"median":-1.117778,"eighty":-0.678869,"marketCap":53764169},{"date":"2024-11-15","current":-2.021598,"twenty":-2.533109,"median":-1.130432,"eighty":-0.681027,"marketCap":46500789},{"date":"2024-11-22","current":-2.381695,"twenty":-2.518403,"median":-1.14924,"eighty":-0.681748,"marketCap":54783743},{"date":"2024-11-29","current":-3.108658,"twenty":-2.536786,"median":-1.1513,"eighty":-0.682216,"marketCap":71505344},{"date":"2024-12-06","current":-3.11317,"twenty":-2.573551,"median":-1.163556,"eighty":-0.682216,"marketCap":71609140},{"date":"2024-12-13","current":-3.339246,"twenty":-2.591933,"median":-1.172916,"eighty":-0.68396,"marketCap":76809340},{"date":"2024-12-20","current":-3.203871,"twenty":-2.63789,"median":-1.181511,"eighty":-0.684358,"marketCap":73695448},{"date":"2024-12-27","current":-3.563968,"twenty":-2.672816,"median":-1.188439,"eighty":-0.685575,"marketCap":81978401},{"date":"2025-01-03","current":-3.575701,"twenty":-2.963439,"median":-1.199602,"eighty":-0.68634,"marketCap":82248272},{"date":"2025-01-10","current":-3.361357,"twenty":-3.040607,"median":-1.208497,"eighty":-0.686647,"marketCap":77317942},{"date":"2025-01-17","current":-2.770672,"twenty":-3.040607,"median":-1.21724,"eighty":-0.686647,"marketCap":63730993},{"date":"2025-01-24","current":-2.828883,"twenty":-3.024274,"median":-1.223533,"eighty":-0.686647,"marketCap":65069966},{"date":"2025-01-31","current":-2.617247,"twenty":-3.024094,"median":-1.237957,"eighty":-0.686716,"marketCap":60201915},{"date":"2025-02-07","current":-2.748109,"twenty":-3.018318,"median":-1.240213,"eighty":-0.687011,"marketCap":63212011},{"date":"2025-02-14","current":-2.526997,"twenty":-2.995124,"median":-1.253371,"eighty":-0.687089,"marketCap":58125987},{"date":"2025-02-21","current":-2.752171,"twenty":-2.98321,"median":-1.265307,"eighty":-0.687089,"marketCap":63305428},{"date":"2025-02-28","current":-2.547303,"twenty":-2.969222,"median":-1.266783,"eighty":-0.687841,"marketCap":58593071},{"date":"2025-03-07","current":-2.484128,"twenty":-2.959584,"median":-1.282075,"eighty":-0.687975,"marketCap":57139921},{"date":"2025-03-14","current":-2.627626,"twenty":-2.949818,"median":-1.288064,"eighty":-0.690926,"marketCap":60440647},{"date":"2025-03-21","current":-2.928609,"twenty":-2.949818,"median":-1.299855,"eighty":-0.691962,"marketCap":67363867},{"date":"2025-03-28","current":-2.826627,"twenty":-2.949818,"median":-1.307109,"eighty":-0.693906,"marketCap":65018068},{"date":"2025-04-04","current":-1.922894,"twenty":-2.928609,"median":-1.318962,"eighty":-0.694106,"marketCap":70625965},{"date":"2025-04-11","current":-1.727671,"twenty":-2.901985,"median":-1.32709,"eighty":-0.694593,"marketCap":63455634},{"date":"2025-04-17","current":-1.948967,"twenty":-2.874911,"median":-1.350812,"eighty":-0.695108,"marketCap":71583605},{"date":"2025-04-25","current":-2.085851,"twenty":-2.836735,"median":-1.358206,"eighty":-0.696326,"marketCap":76611216},{"date":"2025-04-30","current":-2.098887,"twenty":-2.827981,"median":-1.370824,"eighty":-0.696598,"marketCap":77090036}],"updateTime":1746128140247}}}